Insys Therapeutics, Inc. 4
4 · Insys Therapeutics, Inc. · Filed Sep 22, 2015
Insider Transaction Report
Form 4
Babich Michael L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2015-09-22−16,068→ 70,000 totalExercise: $1.62Exp: 2021-03-27→ Common Stock (16,068 underlying) - Exercise/Conversion
Common Stock
2015-09-22$1.62/sh+16,068$26,030→ 421,572 total
Footnotes (4)
- [F1]On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 202,752 additional shares.
- [F2]The exercise price reflects a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
- [F3]The option vested in 48 equal monthly installments and was fully vested and exercisable on March 28, 2015.
- [F4]On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 43,034 additional options.